|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 332.00 EUR | -0.75% |
|
+1.84% | -7.13% |
| 07-21 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 |  |
| 07-21 | Despite the escalation in the Middle East, European stocks stay the course |  |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 412 | +24.1% | 8 | ||||||
| 113.82 | +51.06% | 17 | ||||||
| 30.07 | +20.72% | 14 | ||||||
| - | 17.35 | +117.69% | 2 | |||||
| 3.256 | +6.39% | 6 | ||||||
| 14.42 | +28.87% | 4 | ||||||
| - | 45.6 | +33.98% | 5 | |||||
| 20.41 | +31.42% | 3 | ||||||
| 90.38 | +26.4% | 4 | ||||||
| 9 | +43.54% | 2 | ||||||
| 18.5 | +50.16% | 2 | ||||||
| 14.75 | +48.24% | 2 | ||||||
| 39.5 | +79.14% | 2 | ||||||
| Average | 63.77 | +43.21% | 5 | ||||||
| Weighted average by Cap. | 92.32 | +44.28% | 13 |
- Stock Market
- Stocks
- VIRP Stock
- Sector Virbac
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
